Sol-Millennium
Medical Group
We are one of the world's largest manufacturers of needles and syringes. We are vertically integrated with locations across the globe. Our innovative technology helps reduce unnecessary injuries, saves on medication and enhances both clinician and patient experience. Our international sales team is dedicated to delivering knowledge and outstanding customer service. Our goal is to partner with those in healthcare, focusing on a healthier tomorrow.
Sol-Millennium: Through the Years
A History of Success and Innovation
1982
The Beginning
This is where it all started thanks to Mr. Lin Zuoqian and his expertise in the field of precision plastic mold manufacturing
2007
Sol-Millennium Medical
This is where the story begins for Sol-Millennium Medical Incorporated in Shanghai, China with the sole purpose of building a healthier tomorrow through innovative, safety-engineered medical devices.
2009
Globalization
Sol-Millennium enters the North American and Brazilian markets with Sol-Care™ branded safety syringes through the acquisition of Inviro Medical Inc. and Medica Brazil. The company also establishes EMEA office in Poland, serving Europe and the Middle East.
2015
Powering Innovation
Sol-Millennium introduces Sol-Care™ branded safety needles and the world’s first tube set with a vacuum retractable safety blood collection device. The Company expands to Switzerland by founding a dedicated R&D Center powered by some of the most creative minds in the medical industry.
2019
Covid-19 Response
To better support global customers, Sol-Millennium relocates its corporate headquarters to Chicago. A year later the company becomes one of the key responders to the COVID-19 pandemics during worldwide PPE shortages, vaccination campaigns and diagnostic screenings. In 2021 Sol-Millennium supplies over two billion syringes and needles for Covid-19 global vaccination programs.
2022
A Bright Future
Sol-Millennium signs its first GPO agreement with Premier for standard and safety needles and syringes, solidifying its presence in the US market. Sol-Guard® Safety Pull Button Blood Collection Set is recognized with two prestigious, world-renowned, industrial design awards for product excellence and innovation in safety; the Red Dot and iF Design Awards.
Mission
Building a Healthier Tomorrow. It is a promise we made to our customers and the society. We will continually protect the safety of healthcare workers, patients and the environment by providing innovative, high quality medical devices. environment by providing innovative, high quality medical devices.
Innovation
With R&D centers based in Asia and Europe, we have a rich pipeline of new product innovation, and ambitious plans to grow our brands and our business. Close collaboration with front-line healthcare professionals is critical to the way we work. By sharing knowledge and ideas together we continuously improve our offer and work toward our goal of ‘Building a Healthier Tomorrow’.
.JPG)
Our Products
We currently manufacture a range of safety syringes and needles under the Sol-Care and Sol-Guard brands. We also produce syringes and needles for the veterinary industry under the Sol-Vet line of products, as well as an extensive range of standard (non-safety) needles and syringes. Our products are available through our distribution network worldwide.
Why Sol-Millennium?
Our team is committed to improving the safety and well-being of healthcare workers, patients and downstream workers by reducing the risk of needlestick injury.
We offer a variety of patented products designed to assist healthcare workers in delivering the best care possible.
As a global healthcare company, we are dedicated to research and develop innovative products that meet changing clinical needs to promote a healthier tomorrow.
Sol-Millennium Group has a global reach with offices in Shanghai (Asia Pacific), Chicago (North America), Sao Paulo (South America) and Warsaw (EMEA).
Sol M is committed to being proactive in maintaining compliance to adhere the highest standards of quality and safety.
.png)
.png)
